Issue #50 · August 26
K-Bio is making bigger moves,
with record licensing deals, major global partnerships and new opportunities across the bio industry 😄
And this week, we're celebrating our 50th edition.🎉
This edition highlights Korea's latest biotech milestones — from a landmark drug deal to licensing deals nearing a record high. Stay tuned till the end for more K-Bio updates!
THIS WEEK: 
WHAT WE'VE BEEN UP TO
Feed the World!🌱
KoreaBIO hosted the 2026 Biofood Media Day in Seoul on August 20, where industry experts and media to explore the future of biofood!
Advancing Expertise!🧬
KoreaBIO hosted a 2-day professional training program on Toxicity Testing Methods(ICH) and Result Interpretation  for bioindustry professionals on August 18-19.
KoreaBIO MEMBER NEWS
 Welcome abroad 🎉🤝 
We are delighted to have three new member companies join KoreaBIO!

IMVASTECH specializes in developing novel anti-inflammatory antibody therapeutics targeting specific immune cells for the treatment of atherosclerosis and ASCVD.

Baobab AiBIO Selected as Lead Institution for the Ministry of Science and ICT’s “Quantum Advantage Challenge Research” Program in Drug Development.

C&R Research to Host Encore “RWE Practical Roadmap” Seminar on September 1.

NeoImmuneTech Signs First Post-IPO Licensing Deal with U.S. Biotech Company Valued at KRW 367 Billion.

Insilicogen to Host 78th IncoSeminar on “IPA User Group Meeting” on September 8.

Insilicogen to Host 79th IncoSeminar on “Finding Biomarkers from Public Omics Data” on September 10.

Prestige Biopharma IDC to Host “2026 Prestige Symposium: Frontiers in Aging Mechanisms and Age-Related Diseases” on September 4.

Willog Insurance to Host Webinar on Cargo Insurance Coverage Gaps on September 9.

Dt&CRO Signs MOU with Matica Biolabs for End-to-End Drug Development Through One-Stop CDMO and CRO Services.

IVIM Technology Obtains Medical Device Manufacturing Certification for Robotic-Arm Two-Photon Intravital Microscope for Real-Time Intraoperative Cancer Tissue Diagnosis.

Oscotec Files Trademark Application for RIVENDELL, an AI Screening Platform for Anticancer Drug Resistance.

CHA Biotech Selected for the Ministry of Science and ICT’s K-HERO Development and Support Program.

C&R Research to Host September 16 Webinar on Clinical Data Management in the RBQM Era.

EDITOR'S NOTE
Join us to discover opportunities for collaboration between Korea and Spain! 🇰🇷 🇪🇸
WEBINAR: The Biotech Ecosystem in Korea 2026 📢
KoreaBIO together with ICEX Spain Trade and Investment and the Economic and Commercial Office of the Embassy of Spain in Seoul, will co-host an online webinar!
This webinar will provide Spanish biotech and life sciences companies with insights into Korea’s biotech market, business opportunities, regulatory landscape, and bilateral cooperation programs.
⏰ Date & Time: September 16, 2026 | 18:30-19:30 (KST)
🗣️ Language: English
📌 Registration Deadline: September 15, 2026
Here's what's happening across Korea's bio industry!
WHAT'S HAPPENING
KOREA GOES GLOBAL
INNOVATION & TRENDS
GROWTH & PERFORMANCE
KoreaBIO INSIGHT  
WHAT'S COMING UP?

Learn More? [Visit our Website]

New here? Join 2,700+ insatiably curious readers [Sign up here]

Missed Something? Check up on [Past Issues]

Korea Biotechnology Industry Organization (KoreaBIO)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea